LawCash Links

Recommended

A class action has been filed against Sourcecorp Inc. (Nasdaq: SRCP) and certain of its officers and directors by stockholders who purchased the company's common stock between May 7, 2003 and October 27, 2004. The action claims that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. The stockholder seeks to recover compensatory damages for the loss of value of their stock.

NEW ORLEANS, LA--(MARKET WIRE)--Feb 22, 2006 -- Kahn Gauthier Swick, LLC ("KGS") announces that a securities class action lawsuit has been commenced in the U.S. District Court for the Central District of California, on behalf of shareholders who purchased, exchanged or otherwise acquired the common stock of The Cooper Companies, Inc. (NYSE:COO - News) between July 29, 2004 and November 21, 2005. No class has yet been certified in this action.

Two law firms representing Diebold Inc. investors are suing Diebold Inc., claiming the Ohio company made misleading comments about its electronic voting machine business that led to artificially high share prices. Both lawsuits seek class-action status. Both lawsuits were filed in U.S. District Court in Cleveland and claim Diebold was "unable to assure the quality and working order of its voting machine products."

A class action has been filed against Ligand Pharmaceuticals, Inc., a San Diego, CA based biopharmaceutical company (NASDAQ: LGND) and certain of its officers and directors by stockholders who purchased the company’s common stock between July 28, 2003 and August 2, 2004. The action claims that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company’s securities. The stockholders seek to recover compensatory damages for the loss of value of their stock.

A class action has been filed against Bombardier, Inc., and certain of its officers and directors by stockholders who purchased the company's common stock between Thursday, January 27, 2000 and Tuesday, May 06, 2003. The action claims that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. The stockholders seek to recover compensatory damages for the loss of value of their stock.

Several class actions have been filed against the officers and directors of biotechnology company Organogenesis, Inc. (formerly AMEX: ORG) by stockholders who purchased the company's common stock between November 15, 1999, and January 30, 2002. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities.